The Transition from PCOS to PMOS: A Scientific Recognition of Systemic Disease and Homoeopathic Philosophy, Modern Validation of Homoeopathy’s Constitutional Understanding of Disease

 Prof Dr Sushil Subhashchandra Dubey  

Abstract
In May 2026, a global consensus published in The Lancet officially renamed Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS). This change acknowledges the condition as a complex, multisystem disorder involving endocrine, metabolic, and broader systemic disturbances rather than a primarily ovarian pathology characterised by “cysts.” This article examines the significance of this nomenclature update from a homoeopathic perspective. It highlights that homoeopathy has long recognised such conditions as expressions of a deranged vital force affecting the entire organism, with no organ diseased in isolation. Relevant aphorisms from the sixth edition of Hahnemann’s Organon of Medicine are discussed to underscore this holistic principle. The renaming offers an opportunity for greater integration between conventional medicine and homoeopathy in managing this prevalent condition.

Keywords: Polyendocrine Metabolic Ovarian Syndrome, PMOS, PCOS, homoeopathy, holistic medicine, vital force, Organon of Medicine, local maladies

Introduction
In May 2026, following a comprehensive global consensus process spanning over a decade, Polycystic Ovary Syndrome (PCOS) was officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) in a landmark publication in The Lancet. This update reflects a deeper understanding of the condition’s multisystem pathophysiology. What was previously viewed chiefly as a reproductive disorder focused on ovarian morphology is now recognised as a polyendocrine and metabolic disorder with far-reaching systemic effects.

The renaming of Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS) was necessitated by the realisation that the original name was scientifically inaccurate and clinically misleading. The term “polycystic” wrongly suggests that the condition revolves around multiple ovarian cysts, whereas in reality, many patients do not show true cystic formations; the ultrasound findings typically represent arrested immature follicles caused by ovulatory dysfunction rather than genuine pathological cysts. The new designation, Polyendocrine Metabolic Ovarian Syndrome, more precisely captures the disorder’s fundamental character as a complex multisystem condition involving widespread endocrine imbalances (particularly insulin and androgen pathways), significant metabolic disturbances such as insulin resistance, obesity, and heightened risk of diabetes and cardiovascular disease, while appropriately retaining reference to its ovarian manifestations, including menstrual irregularities and hyperandrogenism. The previous label promoted a narrow, ovary-centric view that frequently resulted in delayed diagnoses, fragmented treatment focused mainly on fertility concerns while ignoring broader metabolic and long-term health risks, and unnecessary stigma for patients. This nomenclature update emerged from an extensive global consensus effort and was formally announced in, The Lancet, in May 2026, with a phased transition planned until 2028. It aligns naturally with homoeopathy’s longstanding recognition that such disorders reflect a systemic disturbance of the vital force affecting the whole organism rather than arising from any single organ in isolation.

For practitioners of homoeopathy, this shift represents not a novel discovery but a long-overdue validation of principles established by Samuel Hahnemann more than two centuries ago. Homoeopathy has consistently maintained that disease is a dynamic disturbance of the vital force involving the whole organism, never confined exclusively to a single organ.

Homoeopathy’s Long-Standing Holistic Perspective
Homoeopathy asserts that no organ becomes diseased in isolation. The manifestation in one part—such as the ovaries in what was formerly termed PCOS—is merely a local expression of a deeper disturbance affecting the entire economy. Symptoms arise only with the cooperation and participation of multiple systems, including the endocrine, metabolic, nervous, and immunological.

This principle aligns precisely with the rationale behind the renaming to PMOS. Conventional medicine is now explicitly acknowledging what Hahnemann taught: treating local symptoms alone fails to address the totality of the disorder. Genuine restoration of health requires individualised treatment of the patient as a unified whole—mind, body, and vital force—guided by the complete symptom picture.

Hahnemann’s Teachings: Aphorisms from the 6th Edition of the Organon of Medicine
Hahnemann’s teachings on this subject are particularly explicit in the sections addressing local maladies. (§§186–§190). He critiques the notion of diseases limited to particular parts:

“These affections were considered to be merely topical, and were therefore called local diseases, as if they were maladies exclusively limited to those parts wherein the organism took little or no part, or affections of these particular visible parts of which the rest of the living organism, so to speak, knew nothing “One of the many great and pernicious blunders of the old school” (Foot Note 133).

He emphasises that even apparent local issues cannot arise without the consent and involvement of the whole organism.

“And yet very little reflection will suffice to convince us that no external malady (not occasioned by some important injury from without) can arise, persist or even grow worse without some internal cause, without the co-operation of the whole organism, which must consequently be in a diseased state. It could not make its appearance at all without the consent of the whole of the rest of the health, and without the participation of the rest of the living whole (of the vital force that pervades all the other sensitive and irritable parts of the organism); indeed, it is impossible to conceive its production without the instrumentality of the whole (deranged) life; so intimately are all parts of the organism connected together to form an indivisible whole in sensation and functions. No eruption on the lips, no whitlow can occur without previous and simultaneous internal ill-health.” (Aphorism 189)

In these aphorisms, from the 6th edition of Organon of Medicine, Samuel Hahnemann strongly refutes the old medical belief that certain diseases are merely “local” or confined to one visible part of the body. He argues that external manifestations such as eruptions, ulcers, eczema, whitlow, or affections of the lips are not isolated events arising independently on the surface, but outward expressions of an internal disturbance affecting the entire living organism. According to Hahnemann, the human body functions as an indivisible whole governed by the vital force; therefore, no part can become diseased without the participation and consent of the whole system. A skin eruption, for instance, is not simply a defect of the skin itself, just as smoke is not the true cause of a fire but merely its visible indication. Similarly, recurrent mouth ulcers may reflect digestive or constitutional disturbances, and chronic eczema may arise from deeper systemic imbalance rather than from external irritation alone. He emphasises that unless the internal disorder exists, the external lesion cannot originate, persist, or worsen. Hence, merely suppressing local symptoms with topical applications does not cure the patient, because the underlying internal dyscrasia remains untouched and may later manifest in deeper or more serious forms. These aphorisms, therefore, establish one of the fundamental principles of homoeopathy: that disease must always be understood and treated as a dynamic affection of the whole individual rather than as a disconnected local complaint.

All true diseases, according to Hahnemann, are dynamic derangements of the vital force that manifest through the totality of symptoms. This framework explains the success of homoeopathic treatment in PMOS cases through simillimum selection based on the individual’s full symptom totality rather than targeting the ovaries alone.

Implications for Practice and Research
The transition to PMOS provides a valuable opportunity for dialogue between conventional and homoeopathic approaches. While mainstream management increasingly incorporates lifestyle interventions, metabolic support, and endocrine modulation, homoeopathy excels in addressing individual susceptibility and underlying constitutional factors.

Future homoeopathic research could document outcomes in PMOS using totality-based prescribing, contributing to integrative care and a broader understanding of holistic medicine.

Conclusion
The medical community rightly celebrates the nomenclature change to PMOS as scientific progress. For homoeopathy, however, this development simply confirms a truth long embodied in its philosophy and practice: disease is a disturbance of the dynamic vital force expressed through the whole organism, and no single organ suffers alone.

The evolution from PCOS to PMOS marks a welcome step towards a more unified, patient-centred understanding of health and disease—one that homoeopathy has upheld since its foundation.

Prof Dr Sushil Subhashchandra Dubey M.D (Hom)
Professor & HOD, Department of Forensic Medicine, Toxicology  and Medical Jurisprudence,
Pt. Jawaharlal Nehru Govt. Homoeopathic Medical College and Hospital, Kanpur, Uttar Pradesh
Email : drdubeysushil@gmail.com

Be the first to comment

Leave a Reply

Your email address will not be published.


*